"The study was a randomized, double-blind, placebo-controlled, multicenter trial of abagovomab maintenance therapy versus placebo in patients with epithelial ovarian, primary peritoneal, or fallopian tube cancer in first complete clinical remission.","The study randomized, double-blind, placebo-controlled, multicenter trial abagovomab maintenance therapy versus placebo patients epithelial ovarian, primary peritoneal, fallopian tube cancer complete clinical remission.",G0000000|C0557651|C0034656|C0013072|C1706408|C0439743|C0008976|C1832044|C0024501|C0039798|G0000000|C0032042|C0030705|C0221908|C0205065|C0205225|C0031153|G0000000|C0175730|C0006826|C0205197|C0205210|C0544452
Mean age was 66.2 years for lung cancer patients (range = 38–90 years) and 64.6 years for control subjects (range = 38–87 years) at recruitment.,Mean age 66.2 lung cancer patients (range = 38–90 years) 64.6 control subjects (range = 38–87 years) recruitment.,C0444504|C0001779|C0450371|C0024109|C0006826|C0030705|G0000000|C0439234|C0450371|C0243148|C0681850|G0000000|C0439234|C2949735
"The median age of the 490 evaluable patients was 64 years; 65% were women, and 93% were white; 6% had hematologic neoplasms; 25% had severe anemia (ie, Hb < 9.5 g/dL); 48% received platinum-containing chemotherapy; and 66% completed all 16 weeks of the study.","The median age 490 evaluable patients 64 years; 65% women, 93% white; 6% hematologic neoplasms; 25% severe anemia (ie, Hb < 9.5 g/dL); 48% received platinum-containing chemotherapy; 66% completed 16 weeks study.",G0000000|C0549183|C0001779|C1442061|C1516986|C0030705|C0450371|C0439234|C0450371|C0043210|C0450371|C0007457|G0000000|C0018943|C0027651|C0450371|C0205082|C0002871|G0000000|C0019046|G0000000|G0000000|C0439267|C0450371|C1514756|C0032207|C0013216|C0450371|C0205197|C0450371|C0439230|C0557651
"Characteristics of the 888 patients included: mean age, 56.3 years; Eastern Cooperative Oncology Group performance status, ≤ 1 in > 99% of patients; serous papillary subtype, 81.5%; stage III, 85.9%; and cancer antigen 125 ≤ 35U/mL after third cycle, 80.9%.","Characteristics 888 patients included: age, 56.3 years; Eastern Cooperative Oncology Group performance status, ≤ 1 > 99% patients; serous papillary subtype, 81.5%; stage III, 85.9%; cancer antigen 125 ≤ 35U/mL cycle, 80.9%.",C1521970|C1442061|C0030705|C0332257|C0001779|C0450371|C0439234|C1707877|C0679729|C0027651|C0441833|C0597198|C0449438|G0000000|G0000000|G0000000|C0450371|C0030705|C0440743|C0205312|C0449560|C0450371|C0205390|C0439070|C0450371|C0006826|C0003320|C1442061|G0000000|C0439526|C1511572|C0450371
A total of 418 patients 65 years or older were assessed for eligibility.,A total 418 patients 65 assessed eligibility.,G0000000|C0439175|C1442061|C0030705|C0450371|C1516048|C0013893
"A cluster-randomized controlled trial was carried out in Western Myanmar, to evaluate the protective efficacy of village-wide usage of insecticide-impregnated ITNs on malaria incidence and prevalence, anaemia, and the development of children.","A cluster-randomized controlled trial carried Western Myanmar, evaluate protective efficacy village-wide usage insecticide-impregnated ITNs malaria incidence prevalence, anaemia, development children.",G0000000|C1555715|C2587213|C0008976|C0206243|C1705493|C0006416|C0220825|G0000000|C1280519|C0562518|C0457083|C0021576|G0000000|C0024530|C0021149|C0033105|C0002871|C0243107|C0008059
The cluster quasi-randomized stepped-wedge trial was conducted in primary schools in two districts in Western Kenya between January 1998 and December 1999.,The cluster quasi-randomized stepped-wedge trial conducted primary schools districts Western Kenya January 1998 December 1999.,G0000000|C1555715|C0034656|C1261552|C0008976|C0004927|C0205225|C0036375|G0000000|C1705493|C0022558|C3829466|G0000000|C3830550|G0000000
"Exclusion criteria include an anticipated hospital stay of less than twenty-four hours (shorter stays do not provide sufficient time for the assessment, consent, and intervention), inability to communicate or provide signed informed consent, or smoking fewer than six cigarettes per day.","Exclusion criteria anticipated hospital stay twenty-four hours (shorter stays provide sufficient time assessment, consent, intervention), inability communicate provide signed informed consent, smoking fewer cigarettes day.",C0680251|C0243161|C3840775|C0019994|G0000000|C3715070|C0439227|C1282927|G0000000|C1999230|C0205410|C0040223|C1261322|C1511481|C0886296|G0000000|C0566001|C1999230|C1519316|C1522154|C1511481|C0037369|C0205388|C0677453|C0332173
"Exclusion criteria included any major congenital anomaly, any eye anomaly, or any moribund condition.","Exclusion criteria included major congenital anomaly, eye anomaly, moribund condition.",C0680251|C0243161|C0332257|C0205082|C0009678|C0332447|C0015392|C0332447|C0424547|C0012634
"Thirty patients were enrolled, and their mean age was 68.2±10.5 years.","Thirty patients enrolled, age 68.2±10.5 years.",C3816446|C0030705|G0000000|C0001779|G0000000|C0439234
"Enrollees were patients at a large inner-city hospital serving a low-income, predominantly African–American population.","Enrollees patients inner-city hospital serving low-income, African–American population.",G0000000|C0030705|C0557849|C0019994|C1519269|C0032854|G0000000|C0032659
"Patients with a history of thromboembolism within 1 year of enrollment, genetic hemochromatosis, or recent surgery were excluded, as were patients with anemia caused by a myelodysplastic syndrome, nutritional deficiency, or a non-neoplastic hematologic disorder such as thalassemia.","Patients history thromboembolism 1 enrollment, genetic hemochromatosis, surgery excluded, patients anemia caused myelodysplastic syndrome, nutritional deficiency, non-neoplastic hematologic disorder thalassemia.",C0030705|C0019664|C0040038|G0000000|C1516879|C0017296|C0018995|C0038894|C1554077|C0030705|C0002871|C0015127|G0000000|C0039082|C1521739|C0011155|C1709246|C0018943|C0012634|C0039730
Patients with a brain injury and dysphagia were enrolled.,Patients brain injury dysphagia enrolled.,C0030705|C0006104|C3263722|C0011168|G0000000
"Ten patients were excluded after randomization because they refused surgery (n = 3), died before surgery (n = 3), had no cancer (n = 1), had surgery without bowel resection (n = 1), or were switched to palliative care (n = 2).","Ten patients excluded randomization refused surgery (n = 3), died surgery (n = 3), cancer (n = 1), surgery bowel resection (n = 1), switched palliative care (n = 2).",C0014518|C0030705|C1554077|C0034656|C1548564|C0038894|G0000000|C0011065|C0038894|G0000000|C0006826|G0000000|C0038894|C0021853|C0015252|G0000000|C1707719|C0587605|C1947933|G0000000
"Among 1516 enrolled women, 1444 (median age 54, range 40–75) completed both examinations and were included in the analysis.","Among 1516 enrolled women, 1444 (median age 54, range 40–75) completed examinations included analysis.",G0000000|G0000000|G0000000|C0043210|G0000000|C0549183|C0001779|C0450371|C1514721|G0000000|C0205197|C0031809|C0332257|C0002778
"We excluded those with penicillin allergy, serious underlying disease, immunological deficiency, a valvular heart defect, major lesions in the mouth or nose, a grommet in the ear, or chronic otitis media.","We excluded penicillin allergy, underlying disease, immunological deficiency, valvular heart defect, major lesions mouth nose, grommet ear, chronic otitis media.",G0000000|C1554077|C0030827|C0002111|G0000000|C0012634|C0205470|C0011155|C0184252|C0018787|C1457869|C0205082|C0221198|C0226896|C0028429|C0850121|C0013443|C0205191|C0029877|C0009458
"Consecutive patients older than 65 years and scheduled for surgical treatment of nonmetastatic colorectal cancer were considered for inclusion and screened for frailty using the validated Fried Frailty Index20 (1 indicates no frailty; 2-3, intermediate frailty; and 4-5, frailty)21 (see eMethods 1 in Supplement 2 for details about frailty scoring).","Consecutive patients 65 scheduled surgical treatment nonmetastatic colorectal cancer considered inclusion screened frailty validated Fried Frailty Index20 (1 frailty; 2-3, intermediate frailty; 4-5, frailty)21 (see eMethods 1 Supplement 2 details frailty scoring).",C1707491|C0030705|C0450371|C0086960|C0543467|C0039798|C1518409|C0555952|C0006826|C0750591|C0007637|C0220908|C0424594|G0000000|C1825319|C0424594|G0000000|G0000000|C0424594|G0000000|C0205103|C0424594|G0000000|C0424594|C0042789|G0000000|G0000000|C0242295|G0000000|C1522508|C0424594|C0449820
At the second visit (days 8-10) the children were examined by otomicroscopy and excluded from the study if signs or symptoms of infection were still present.,At visit (days 8-10) children examined otomicroscopy excluded study signs symptoms infection present.,G0000000|C0545082|C0439228|C0450371|C0008059|C0332128|G0000000|C1554077|C0557651|C0220912|C0683368|C0009450|C0150312
Hospitalized smokers are eligible for inclusion if they are adults who smoked in the previous 30 days and are interested in staying quit (or planning to quit) upon discharge.,Hospitalized smokers eligible inclusion adults smoked previous 30 days staying quit (or planning quit) discharge.,C0701159|C0337664|C1548635|C0007637|C0001675|C0037366|C0205156|G0000000|G0000000|C0748223|G0000000|C0032074|C0748223|C0012621
"Patients who had suffered a severe traumatic brain injury (Glasgow Coma Scale score after resuscitation ≤ 8 points or neurological deterioration during the first week after trauma) and with refractory intracranial hypertension (intracranial pressure > 20 mmHg) first-tier measures, in accordance with the Brain Trauma Foundation Guidelines.","Patients suffered severe traumatic brain injury (Glasgow Coma Scale score resuscitation ≤ 8 neurological deterioration week trauma) refractory intracranial hypertension (intracranial pressure > 20 mmHg) first-tier measures, Brain Trauma Foundation Guidelines.",C0030705|C0683278|C0205082|C0332663|C0006104|C3263722|G0000000|C0009421|C0175659|C0449820|C0035273|G0000000|G0000000|C0205494|C0868945|C0332174|C0043251|C0205269|C0524466|C0020538|C0524466|C0033095|G0000000|C0450371|C0439475|C0205435|C0079809|C0006104|C0043251|C0016617|C0162791
"In total, 510 study subjects (306 males and 204 females) participated in this study.","In total, 510 study subjects (306 males 204 females) participated study.",G0000000|C0439175|C1442061|C0557651|C0681850|C1442061|C0086582|C1442061|C0015780|G0000000|C0557651
"A prospective, randomized, multicentric, open-labeled, parallel study was undertaken in 83 patients with Dermatophytoses involving tinea corporis and tinea cruris infections.","A prospective, randomized, multicentric, open-labeled, parallel study undertaken 83 patients Dermatophytoses involving tinea corporis tinea cruris infections.",G0000000|C0023981|C0034656|C0439743|C0175566|C2348042|C0557651|G0000000|C0450371|C0030705|C0011636|C1314939|C0040247|G0000000|C0040247|G0000000|C3714514
"130 children prone to otitis media aged between 6 months and 6 years, 108 of whom were eligible and followed for 3 months.","130 children prone otitis media aged 6 months 6 years, 108 eligible 3 months.",C1442061|C0008059|C0033422|C0029877|C0009458|C0001779|G0000000|C0439231|G0000000|C0439234|C1442061|C1548635|G0000000|C0439231
Overall mean age (± standard deviation [SD]) was 56.3 ± 10.53 years.,Overall age (± standard deviation [SD]) 56.3 ± 10.53 years.,C0282416|C0001779|G0000000|C1442989|C0012727|C2699239|C0450371|G0000000|C0450371|C0439234
"The baseline characteristics of the enrolled infants were similar across all three groups, and the median ages at study drug infusion by group were between 2.4 and 3.2 days (Table 1).","The baseline characteristics enrolled infants groups, median ages study drug infusion 2.4 3.2 days (Table 1).",G0000000|C0168634|C1521970|G0000000|C0021270|C0441833|C0549183|C0001779|C0557651|C0013227|C0574032|G0000000|G0000000|C0439228|C0039224|G0000000
"Inclusion criteria were the following: age >17 years, daily smoking ≥5 cpd, interest in quitting smoking within the next 30 days but not actively engaged in quitting, having a phone and home Internet access (including an e-mail address), no prior use of the smokefree.gov Web site, suitability for NRT (e.g., no allergies to NRT, not pregnant [2]), willingness to perform study procedures and have use of the assigned smokefree.gov Web site tracked.","Inclusion criteria following: age >17 years, daily smoking ≥5 cpd, quitting smoking 30 days actively engaged quitting, phone Internet access (including e-mail address), prior smokefree.gov Web site, suitability NRT (e.g., allergies NRT, pregnant [2]), willingness perform study procedures assigned smokefree.gov Web site tracked.",C0007637|C0243161|C0231290|C0001779|C0450371|C0439234|C0332173|C0037369|G0000000|C0085988|C0748223|C0037369|C0450371|C0439228|G0000000|C0425152|C0748223|C1515258|C0282111|C0444454|C0332257|C0013849|C0376649|C0332152|C1419208|C0282111|C0205145|C3900053|C1278444|G0000000|C0020517|C1278444|C0549206|G0000000|C0600109|C0884358|C0557651|C0025664|C1516050|C1419208|C0282111|C0205145|C0040594
"The study was carried out in four semi-urban villages situated near Ile-Ife, Osun State, Nigeria.","The study carried semi-urban villages situated Ile-Ife, Osun State, Nigeria.",G0000000|C0557651|C0206243|C0442529|C0562518|G0000000|C0022192|G0000000|C1301808|C0028075
"Following IRB approval, women were recruited from three prenatal care sites from July 2006 to December 2009, and followed until May 2010.","Following IRB approval, women recruited prenatal care sites July 2006 December 2009, May 2010.",C0231290|C0086911|C0205540|C0043210|G0000000|C0678804|C1947933|C0205145|C3829447|G0000000|C3830550|G0000000|G0000000|G0000000
"Exclusion criteria included recent or current congestive heart failure, myocardial infarction, or cardiac surgery.","Exclusion criteria included current congestive heart failure, myocardial infarction, cardiac surgery.",C0680251|C0243161|C0332257|C0521116|C0742742|C0018787|C0231174|C0027061|C0021308|C0018787|C0038894
"Exclusion criteria included current use of NRT or other nicotine-containing products (such as cigars, pipes, snuff), and current involvement in other smoking cessation or smoking reduction programs.","Exclusion criteria included current NRT nicotine-containing products (such cigars, pipes, snuff), current involvement smoking cessation smoking reduction programs.",C0680251|C0243161|C0332257|C0521116|C1278444|C0028040|C1514468|G0000000|C0678446|C0071109|C0037390|C0521116|C1314939|C0037369|C1880019|C0037369|C0301630|C0376691
"The study was carried out between May 16, 2006, and August 22, 2007, in four semi-urban villages, Akinlalu, Ipetumodu, Moro and Edunabon, situated near Ile-Ife, Osun State, Nigeria.","The study carried May 16, 2006, August 22, 2007, semi-urban villages, Akinlalu, Ipetumodu, Moro Edunabon, situated Ile-Ife, Osun State, Nigeria.",G0000000|C0557651|C0206243|G0000000|C0450371|G0000000|C3831448|C0450371|G0000000|C0442529|C0562518|G0000000|G0000000|G0000000|G0000000|G0000000|C0022192|G0000000|C1301808|C0028075
"83 patients with tinea corporis and tinea cruris infections were enrolled in this multicentre, randomized, open label parallel study.","83 patients tinea corporis tinea cruris infections enrolled multicentre, randomized, label parallel study.",C0450371|C0030705|C0040247|G0000000|C0040247|G0000000|C3714514|G0000000|C0439743|C0034656|C0181496|C2348042|C0557651
"Eligible patients were ≥ 18 years of age and had relapsed high-grade serous or high-grade endometrioid ovarian cancer, primary peritoneal cancer, and/or fallopian tube cancer, with at least 1 lesion (measurable and/or nonmeasurable) that could be accurately assessed at baseline by computed tomography/magnetic resonance imaging and was suitable for repeated assessment.","Eligible patients ≥ 18 age relapsed high-grade serous high-grade endometrioid ovarian cancer, primary peritoneal cancer, and/or fallopian tube cancer, 1 lesion (measurable and/or nonmeasurable) accurately assessed baseline computed tomography/magnetic resonance imaging suitable repeated assessment.",C1548635|C0030705|G0000000|C0450371|C0001779|C0205336|C0205082|C0440743|C0205082|C0014180|C0205065|C0006826|C0205225|C0031153|C0006826|G0000000|G0000000|C0175730|C0006826|G0000000|C0221198|C1513040|G0000000|C1518373|G0000000|C1516048|C0168634|C1441526|C0040395|C0231881|C0011923|C3900053|C0205341|C1261322
"Subjects were 230/7 to 296/7 weeks GA who weighed at least 400g, and could receive study drug by 72hr after birth.","Subjects 230/7 296/7 weeks GA weighed 400g, receive study drug 72hr birth.",C0681850|C1442061|C1442061|C0439230|C0016993|G0000000|G0000000|C1514756|C0557651|C0013227|G0000000|C0005615
A total of 44 patients (22 in each group) were included over a 5-year period.,A total 44 patients (22 group) included 5-year period.,G0000000|C0439175|C0450371|C0030705|C0450371|C0441833|C0332257|C0439234|C0439531
"Patients were excluded if there were any changes to their regular inhaled medications or systemic corticosteroids four weeks before the study or during the study period, and if they had acute or exacerbated allergic bronchopulmonary aspergillosis.","Patients excluded regular inhaled medications systemic corticosteroids weeks study study period, acute exacerbated allergic bronchopulmonary aspergillosis.",C0030705|C1554077|C0205272|C0004048|C0013227|C0205373|C0001617|C0439230|C0557651|C0557651|C0439531|C0205178|C0436331|C0700624|C0545675|C0004030
We conducted a phase III trial (SOLO3) of olaparib tablets versus nonplatinum chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer who had received at least 2 prior lines of platinum-based chemotherapy.,We conducted phase III trial (SOLO3) olaparib tablets versus nonplatinum chemotherapy patients germline BRCA-mutated platinum-sensitive relapsed ovarian cancer received 2 prior lines platinum-based chemotherapy.,G0000000|C0004927|C0205390|C0439070|C0008976|G0000000|C2316164|C0039225|G0000000|G0000000|C0013216|C0030705|C0017473|C1705285|C0032207|C0205336|C0205065|C0006826|C1514756|G0000000|C0332152|C0205132|C0032207|C0013216
"Eligibility criteria included receiving an AI for at least 6 months, reporting ≥ 3 of 10 for worst joint pain on the Brief Pain Inventory (BPI), and reporting < 90 minutes per week of aerobic exercise and no strength training.","Eligibility criteria included receiving AI 6 months, reporting ≥ 3 10 worst joint pain Brief Pain Inventory (BPI), reporting < 90 minutes week aerobic exercise strength training.",C0013893|C0243161|C0332257|C1514756|C0003353|G0000000|C0439231|C0700287|G0000000|G0000000|C0450371|C1522166|C0022417|C0030193|C1282927|C0030193|C0021941|C1443145|C0700287|G0000000|C0450371|C0439232|C0332174|C1510824|C0015259|C0237897|C0040607
"Exclusion criteria included pregnancy, breast feeding, concurrent use of any other forms of tobacco or other nicotine-containing products, myocardial infarction within 3 months, unstable angina, serious arrhythmias, terminal illness, systemic dermatologic disorders such as psoriasis or eczema, and self-reported alcohol or drug dependency.","Exclusion criteria included pregnancy, breast feeding, concurrent forms tobacco nicotine-containing products, myocardial infarction 3 months, unstable angina, arrhythmias, terminal illness, systemic dermatologic disorders psoriasis eczema, self-reported alcohol drug dependency.",C0680251|C0243161|C0332257|C0032961|C0006141|C0204695|C0205420|C0348078|C0040329|C0028040|C1514468|C0027061|C0021308|G0000000|C0439231|C0443343|C0002962|C0003811|C0205088|C0221423|C0205373|C0205489|C0012634|C0033860|C0013595|C0681906|C0001962|C0013227|C0011546
Subjects are only eligible for the study if they intend to stay quit (or plan to quit) after discharge.,Subjects eligible study intend stay quit (or plan quit) discharge.,C0681850|C1548635|C0557651|G0000000|G0000000|C0748223|G0000000|C0270724|C0748223|C0012621
"Eligible subjects were 230/7–296/7 weeks gestation, ≥ 600 g birth weight, had no major congenital anomalies, were between 12 h and 6 days of age at randomization, and had received no human milk or formula feedings since birth.","Eligible subjects 230/7–296/7 weeks gestation, ≥ 600 birth weight, major congenital anomalies, 12 6 days age randomization, received human milk formula feedings birth.",C1548635|C0681850|G0000000|C0439230|C0032961|G0000000|C1442061|C0005615|C0005910|C0205082|C0009678|C0000769|C0450371|G0000000|C0439228|C0001779|C0034656|C1514756|C0086418|C0026131|C0489829|C0204695|C0005615
Approximately 10500 pupils were enrolled in each group (Table 1).,Approximately 10500 pupils enrolled (Table 1).,C0332232|G0000000|C0034121|G0000000|C0039224|G0000000
Patients between 35–80 years of age hospitalized with acute ischemic stroke and hemiplegia were included.,Patients 35–80 age hospitalized acute ischemic stroke hemiplegia included.,C0030705|G0000000|C0001779|C0701159|C0205178|C0475224|C0038454|C0018991|C0332257
"Thus, eligible women had to be receiving an AI and planning to continue to take the medication for 1 year; women also had to be experiencing at least mild AI-associated arthralgia.","Thus, eligible women receiving AI planning continue medication 1 year; women experiencing mild AI-associated arthralgia.",G0000000|C1548635|C0043210|C1514756|C0003353|C0032074|C0549178|C0013227|G0000000|C0439234|C0043210|C0237607|C2945599|C0003353|C0003862
"Patients with onset of stroke between two to seven days beforehand, the NIHSS score between 5 and 14, and displaying clear consciousness and stable vital signs were only included if it was their first incidence of stroke.","Patients onset stroke days beforehand, NIHSS score 5 14, displaying consciousness stable vital signs included incidence stroke.",C0030705|C0206132|C0038454|C0439228|G0000000|C3476804|C0449820|G0000000|C0450371|C0870432|C0009791|C0205360|C0442732|C0220912|C0332257|C0021149|C0038454
The outcome is based on measurements from 27 995 children.,The outcome based measurements 27 995 children.,G0000000|C1274040|C1527178|C0242485|C0450371|C1442061|C0008059
Fifty preterm infants less than 37 weeks with weight less than 1500 g were enrolled in the study.,Fifty preterm infants 37 weeks weight 1500 enrolled study.,C3816723|C0151526|C0021270|C0450371|C0439230|C0005910|G0000000|G0000000|C0557651
"Women with a history of benign breast biopsy, remote history of treated breast cancer, or family history of breast cancer were eligible.","Women history benign breast biopsy, remote history treated breast cancer, family history breast cancer eligible.",C0043210|C0019664|C0205183|C0006141|C0005558|C0205157|C0019664|C1522326|C0006141|C0006826|C0015576|C0019664|C0006141|C0006826|C1548635
"Eligible patients had a history of histologically and serologically CA-125–confirmed diagnosis (CA-125 > 35 U/mL) of stage III to IV epithelial ovarian, fallopian tube, or primary peritoneal cancer.","Eligible patients history histologically serologically CA-125–confirmed diagnosis (CA-125 > 35 U/mL) stage III IV epithelial ovarian, fallopian tube, primary peritoneal cancer.",C1548635|C0030705|C0019664|C0205462|G0000000|G0000000|C0011900|C3887642|G0000000|C0450371|C0439340|C0205390|C0439070|C0022326|C0221908|C0205065|G0000000|C0175730|C0205225|C0031153|C0006826
"Consent was obtained for 79, 76 were randomized, and 74 received study drug.","Consent 79, 76 randomized, 74 received study drug.",C1511481|C0450371|C0450371|C0034656|C0450371|C1514756|C0557651|C0013227
"To be eligible, smokers were required to be at least 18 years old, to have smoked in the past 7 days, and to have smoked more than 100 cigarettes in their lifetime.","To eligible, smokers required 18 old, smoked 7 days, smoked 100 cigarettes lifetime.",C0040363|C1548635|C0337664|C1514873|C0450371|C0580836|C0037366|G0000000|C0439228|C0037366|C1442061|C0677453|C4071830
"Study design—From 1996 to 1999 we performed a double blind, randomised study with two arms on 130 children aged between 6 months and 6 years.","Study design—From 1996 1999 performed double blind, randomised study arms 130 children aged 6 months 6 years.",C0557651|G0000000|G0000000|G0000000|C0884358|C0205173|C0150108|G0000000|C0557651|C0206655|C1442061|C0008059|C0001779|G0000000|C0439231|G0000000|C0439234
"Of these, 298 patients were excluded (not frail [n = 290], unable to exercise [n = 3], and planned neoadjuvant treatment [n = 5]), and 120 frail patients (Fried Frailty Index,≥2) were randomized.","Of these, 298 patients excluded (not frail [n = 290], unable exercise [n = 3], planned neoadjuvant treatment [n = 5]), 120 frail patients (Fried Frailty Index,≥2) randomized.",G0000000|G0000000|C1442061|C0030705|C1554077|C1518422|C0871754|G0000000|C1299582|C0015259|G0000000|C1301732|C0600558|C0039798|G0000000|C1442061|C0871754|C0030705|C1825319|C0424594|G0000000|C0034656
"Patients were excluded from the study, if they had clinical diagnosis of tinea pedis/manum, received topical or oral antimycotics either one or four weeks prior to the initiation of the study respectively, history of hypersensitivity to study drugs, immunocompromised status, superadded bacterial infection or pregnant or lactating women.","Patients excluded study, clinical diagnosis tinea pedis/manum, received topical oral antimycotics weeks prior initiation study respectively, history hypersensitivity study drugs, immunocompromised status, superadded bacterial infection pregnant lactating women.",C0030705|C1554077|C0557651|C0205210|C0011900|C0040247|G0000000|C1514756|C0332237|C0442027|G0000000|C0439230|C0332152|C0589507|C0557651|G0000000|C0019664|C0020517|C0557651|C0013227|C0085393|C0449438|G0000000|C0521009|C0009450|C0549206|C2828358|C0043210
"From August 2004 to October 2008, a total of 241 lung cancer patients (International Classification of Diseases, 9th revision; ICD code 162) were recruited from Changhwa Christian Hospital (Changhwa County, Taiwan).","From August 2004 October 2008, total 241 lung cancer patients (International Classification Diseases, 9th revision; ICD code 162) recruited Changhwa Christian Hospital (Changhwa County, Taiwan).",G0000000|C3831448|G0000000|C3828732|G0000000|C0439175|C1442061|C0024109|C0006826|C0030705|C1512888|C0008902|C0012634|G0000000|C0439617|C0021122|C0009219|C1442061|G0000000|G0000000|C0008532|C0019994|G0000000|C0079170|C0039260
"Patients—Children eligible for inclusion in our study were those who had had recurrent otitis media and who had been either referred by their general practitioner or a paediatrician to the open care unit of the ear, nose, and throat department at Lundby Hospital or were directly seeking medical advice for ear pain.","Patients—Children eligible inclusion study recurrent otitis media referred practitioner paediatrician care unit ear, nose, throat department Lundby Hospital directly seeking medical advice ear pain.",G0000000|C1548635|C0007637|C0557651|C2945760|C0029877|C0009458|C0205543|C1709627|C0237433|C1947933|C0439148|C0013443|C0028429|C0031354|C1704729|G0000000|C0019994|C1947931|G0000000|C0199168|C0150600|C0013443|C0030193
To determine whether abagovomab maintenance therapy prolongs recurrence-free (RFS) and overall survival (OS) in patients with ovarian cancer in first clinical remission.,To determine abagovomab maintenance therapy prolongs recurrence-free (RFS) survival (OS) patients ovarian cancer clinical remission.,C0040363|G0000000|C1832044|C0024501|C0039798|G0000000|C0034897|C0341703|C0038952|C0229090|C0030705|C0205065|C0006826|C0205210|C0544452
A total of 32 patients with a mean (± SD) age of 18.5±8.6 years were included in the study.,A total 32 patients (± SD) age 18.5±8.6 included study.,G0000000|C0439175|C0450371|C0030705|G0000000|C2699239|C0001779|G0000000|C0332257|C0557651
"A randomised, double-blind, placebo-controlled trial was conducted in Entebbe, Uganda [ISRCTN32849447].","A randomised, double-blind, placebo-controlled trial conducted Entebbe, Uganda [ISRCTN32849447].",G0000000|G0000000|C0013072|C1706408|C0008976|C0004927|G0000000|C0041573|G0000000
"Of 2345 live births, 1622 (69%) children remained in follow-up at age 5 years.","Of 2345 live births, 1622 (69%) children remained follow-up age 5 years.",G0000000|G0000000|C1548795|C0005615|G0000000|C0450371|C0008059|G0000000|C0589120|C0001779|G0000000|C0439234
"Adults between the age of 18 and 70 years, with clinical diagnosis and mycological confirmation (positive KOH test) for tinea corporis and tinea cruris infections, were included in the study.","Adults age 18 70 years, clinical diagnosis mycological confirmation (positive KOH test) tinea corporis tinea cruris infections, included study.",C0001675|C0001779|C0450371|C0450371|C0439234|C0205210|C0011900|C0205467|C0521091|C0439178|C0071767|C0022885|C0040247|G0000000|C0040247|G0000000|C3714514|C0332257|C0557651
Two hundred and fifty patients were strictly included in the study and were randomly assigned to the two treatment groups (AG or NAG).,Two fifty patients strictly included study randomly assigned treatment (AG NAG).,C0205448|C3816723|C0030705|G0000000|C0332257|C0557651|G0000000|C1516050|C0039798|C0002037|C1709111
The mean age of the children was 23 months.,The age children 23 months.,G0000000|C0001779|C0008059|C0450371|C0439231
Patients with known autoimmune disease requiring treatment with immunosuppressive agents were excluded.,Patients autoimmune disease requiring treatment immunosuppressive agents excluded.,C0030705|C0443146|C0012634|G0000000|C0039798|C0021081|C0450442|C1554077
Patients were also temporarily excluded if they had received an ESA within 3 months or red cell transfusion within 14 days.,Patients temporarily excluded received ESA 3 months red cell transfusion 14 days.,C0030705|G0000000|C1554077|C1514756|C3890206|G0000000|C0439231|C0332575|C0007634|C0005841|C0450371|C0439228
"Out of the 325 eligible subjects, 314 smokers (131 males, 183 females), recruited between January and May 1999 entered the trial (11 enrolled subjects never attended baseline).","Out 325 eligible subjects, 314 smokers (131 males, 183 females), recruited January May 1999 entered trial (11 enrolled subjects attended baseline).",C0439787|C1442061|C1548635|C0681850|C1442061|C0337664|C1442061|C0086582|C1442061|C0015780|G0000000|C3829466|G0000000|G0000000|C1521975|C0008976|C0450371|G0000000|C0681850|C1456498|C0168634
"Hence, 110 patients were included in the intention-to-treat analysis (55 in the prehabilitation [Prehab] and 55 in the rehabilitation [Rehab] groups).","Hence, 110 patients included intention-to-treat analysis (55 prehabilitation [Prehab] 55 rehabilitation [Rehab] groups).",G0000000|C1442061|C0030705|C0332257|C0162425|C0002778|C0450371|G0000000|G0000000|C0450371|C0034991|C0034991|C0441833
"The mean gestational age was 26 weeks, the mean birthweight was 780 g, and 53% of enrollees were younger than 26 weeks’ gestational age.","The gestational age 26 weeks, birthweight 780 g, 53% enrollees 26 weeks’ gestational age.",G0000000|C0439671|C0001779|C0450371|C0439230|C0005612|C1442061|C0439267|C0450371|G0000000|C0450371|G0000000|C0439671|C0001779
"Participants were recruited from three area hospitals, including two in central Connecticut (Hartford Hospital and New Britain General Hospital) and one in western Massachusetts (Baystate Medical Center).","Participants recruited hospitals, including central Connecticut (Hartford Hospital New Britain General Hospital) western Massachusetts (Baystate Medical Center).",C0679646|G0000000|C0019994|C0332257|C0205099|C0009778|G0000000|C0019994|C0205314|G0000000|C0205246|C0019994|C1705493|C0024874|G0000000|C0199168|C0205099
Infants who had feeding intolerance and enteral feeding could not advanced were excluded from the study.,Infants feeding intolerance enteral feeding advanced excluded study.,C0021270|C0204695|C0231199|C1304890|C0204695|C0205179|C1554077|C0557651
"Exclusions included death before 12hrs, major congenital anomalies, severe oliguria, or a moribund state.","Exclusions included death 12hrs, major congenital anomalies, severe oliguria, moribund state.",C0680251|C0332257|C0011065|G0000000|C0205082|C0009678|C0000769|C0205082|C0028961|C0424547|C1301808
"Participants were 194 low-income, ethnically diverse pregnant smokers.","Participants 194 low-income, ethnically diverse pregnant smokers.",C0679646|C1442061|C0032854|G0000000|C1880371|C0549206|C0337664
"Between February 2006 and December 2008, 502 patients enrolled at 14 MCCRC sites.","Between February 2006 December 2008, 502 patients enrolled 14 MCCRC sites.",G0000000|C3830166|G0000000|C3830550|G0000000|C1442061|C0030705|G0000000|C0450371|G0000000|C0205145
"Randomized clinical trial included 638 infants younger than 28 weeks’ gestational age enrolled from 18 neonatal intensive care centers throughout the United States from April 17, 2014, to September 4, 2015; final date of follow-up was February 12, 2016.","Randomized clinical trial included 638 infants 28 weeks’ gestational age enrolled 18 neonatal intensive care centers United States April 17, 2014, September 4, 2015; final follow-up February 12, 2016.",C0034656|C0205210|C0008976|C0332257|C1442061|C0021270|C0450371|G0000000|C0439671|C0001779|G0000000|C0450371|C1552240|C0162425|C1947933|C0205099|C0166872|C1301808|C3715024|C0450371|G0000000|C3828193|G0000000|G0000000|C0205088|C0589120|C3830166|C0450371|G0000000
"Infants born with congenital abnormalities, had intolerance to enteral feedings, or any medical condition as hyperbilirubinemia requiring phototherapy, hypoglycemia, hyponatremia or respiratory illness necessitating any kind of assisted ventilation or their mothers had contraindication to breastfeeding were not eligible for our study (Figure 1).","Infants born congenital abnormalities, intolerance enteral feedings, medical condition hyperbilirubinemia requiring phototherapy, hypoglycemia, hyponatremia respiratory illness necessitating assisted ventilation mothers contraindication breastfeeding eligible study (Figure 1).",C0021270|C0005615|C0009678|C0000768|C0231199|C1304890|C0204695|C0199168|C0012634|C0020433|G0000000|C0031765|C0020615|C0020625|C0521346|C0221423|G0000000|C1269765|C0035203|C0026591|C0522473|C0006147|C1548635|C0557651|G0000000|G0000000
"Patients were excluded if they (1) had a Fried Frailty Index of 1, (2) did not speak English or French, (3) had metastatic cancer, or (4) had premorbid conditions (ie, cardiorespiratory, musculoskeletal, and/or neurological) that contraindicated exercise and fitness assessments.","Patients excluded (1) Fried Frailty Index 1, (2) speak English French, (3) metastatic cancer, (4) premorbid conditions (ie, cardiorespiratory, musculoskeletal, and/or neurological) contraindicated exercise fitness assessments.",C0030705|C1554077|G0000000|C1825319|C0424594|C0918012|G0000000|G0000000|C0234856|C0376245|C0376246|G0000000|C0036525|C0006826|G0000000|G0000000|C0012634|G0000000|G0000000|C0497254|G0000000|C0205494|C1444657|C0015259|C1456706|C1261322
"Women were eligible if their CO levels were ≥8 ppm, salivary cotinine levels were ≥20 ng/ml, or urinary cotinine levels were ≥100 ng/ml.","Women eligible CO levels ≥8 ppm, salivary cotinine levels ≥20 ng/ml, urinary cotinine levels ≥100 ng/ml.",C0043210|C1548635|C3245499|C0441889|G0000000|C0439187|C0442040|C0010194|C0441889|G0000000|C0439275|C0042027|C0010194|C0441889|G0000000|C0439275
"Inclusion criteria were preterm (gestational age <37 weeks), and very low birth weight (birth weight <1500 g) infants, no intolerance to enteral feedings, enteral feeding volume of 100 mL/kg/day, and mothers willing to provide breast milk by manual breast bump.","Inclusion criteria preterm (gestational age <37 weeks), low birth weight (birth weight <1500 g) infants, intolerance enteral feedings, enteral feeding volume 100 mL/kg/day, mothers provide breast milk manual breast bump.",C0007637|C0243161|C0151526|C0439671|C0001779|C0450371|C0439230|C0205251|C0005615|C0005910|C0005615|C0005910|G0000000|C0439267|C0021270|C0231199|C1304890|C0204695|C1304890|C0204695|C0449468|C1442061|C1532579|C0026591|C1999230|C0006141|C0026131|C0024763|C0006141|G0000000
"Subjects were enrolled if they reported being self-motivated to quit smoking; this was determined by an affirmative response to the question, “Are you motivated to quit smoking?”","Subjects enrolled reported self-motivated quit smoking; determined affirmative response question, “Are motivated quit smoking?”",C0681850|G0000000|C0684224|C0036588|C0748223|C0037369|G0000000|G0000000|C0871261|C1522634|G0000000|G0000000|C0748223|G0000000
Participants: Target is recruitment of 60 adults with acute arm weakness due to suspected stroke (within 3 hours of symptom onset) and hypertension (systolic BP>160 mmHg).,Participants: Target recruitment 60 adults acute arm weakness suspected stroke (within 3 hours symptom onset) hypertension (systolic BP>160 mmHg).,C0679646|C1521840|C2949735|C0450371|C0001675|C0205178|C0446516|C3714552|C0332147|C0038454|G0000000|G0000000|C0439227|C1457887|C0206132|C0020538|C0039155|C0037623|C0439475
"Of 132 children included, 108 (82%) were eligible for analysis of efficacy (53 in the α spray group and 55 in the placebo group) and 126 (95%) for analysis of adverse events.","Of 132 children included, 108 (82%) eligible analysis efficacy (53 α spray 55 placebo group) 126 (95%) analysis adverse events.",G0000000|C1442061|C0008059|C0332257|C1442061|C0450371|C1548635|C0002778|C1280519|C0450371|G0000000|C1704413|C0450371|C0032042|C0441833|C1442061|C0450371|C0002778|G0000000|C0441471
[Subjects and Methods] A total of 18 stroke patients with dysphagia were enrolled in the study.,[Subjects Methods] A total 18 stroke patients dysphagia enrolled study.,C0681850|C0025663|G0000000|C0439175|C0450371|C0038454|C0030705|C0011168|G0000000|C0557651
"A total of 8,175 children were recruited from twenty clusters.","A total 8,175 children recruited twenty clusters.",G0000000|C0439175|C1442061|C0008059|G0000000|C0724000|C1555715
"Infants born before 28 0/7 weeks of gestation, surviving for at least 12 hours, and admitted to 1 of the 18 Neonatal Research Network centers before 72 hours’ postnatal age were screened for eligibility (Figure).","Infants born 28 0/7 weeks gestation, surviving 12 hours, admitted 1 18 Neonatal Research Network centers 72 hours’ postnatal age screened eligibility (Figure).",C0021270|C0005615|C0450371|G0000000|C0439230|C0032961|C0310255|C0450371|C0439227|C0184666|G0000000|C0450371|C1552240|C0035168|C0150775|C0205099|C0450371|G0000000|C0443281|C0001779|C0220908|C0013893|G0000000
"Eligible patients were ≥ 18 years old; were receiving chemotherapy for a nonmyeloid neoplasm; and had Hb less than 11.0 g/dL, ferritin greater than 20 ng/mL, transferrin saturation less than 60%, and a Zubrod performance score better than 2.","Eligible patients ≥ 18 old; receiving chemotherapy nonmyeloid neoplasm; Hb 11.0 g/dL, ferritin 20 ng/mL, transferrin saturation 60%, Zubrod performance score 2.",C1548635|C0030705|G0000000|C0450371|C0580836|C1514756|C0013216|G0000000|C0027651|C0019046|C0450371|C0439267|C0015879|C0450371|C0439275|C0040679|C0522534|C0450371|C3714786|C0597198|C0449820|G0000000
"This single-blind, parallel-arm, superiority randomized clinical trial recruited patients undergoing colorectal cancer resection from September 7, 2015, through June 19, 2019.","This single-blind, parallel-arm, superiority randomized clinical trial recruited patients undergoing colorectal cancer resection September 7, 2015, June 19, 2019.",G0000000|C0242570|C2348042|C0680218|C0034656|C0205210|C0008976|G0000000|C0030705|G0000000|C0555952|C0006826|C0015252|C3828193|G0000000|G0000000|C3829443|C0450371|G0000000
Fifty-seven dysphagic stroke patients were enrolled in a VFSS within 10 days after stroke onset.,Fifty-seven dysphagic stroke patients enrolled VFSS 10 days stroke onset.,C3816723|G0000000|C0038454|C0030705|G0000000|G0000000|C0450371|C0439228|C0038454|C0206132
"The complete cohort consisted of 9,237 patients enrolled by North American institutions on 1 of 5 NWTS protocol studies between October, 1969 and April, 2002.","The complete cohort consisted 9,237 patients enrolled North American institutions 1 5 NWTS protocol studies October, 1969 April, 2002.",G0000000|C0205197|C0599755|C0332529|C1442061|C0030705|G0000000|C1709269|C0596070|C1272753|G0000000|G0000000|C1513906|C0442711|C0947630|C3828732|G0000000|C3715024|G0000000
"A total of 24 subjects with subacute ischemic stroke were recruited; the mean ages of patients in groups A and B were 66.1±11.2 years and 60.9±11.4 years, respectively.","A total 24 subjects subacute ischemic stroke recruited; ages patients A B 66.1±11.2 60.9±11.4 years, respectively.",G0000000|C0439175|C0450371|C0681850|C0205365|C0475224|C0038454|G0000000|C0001779|C0030705|G0000000|G0000000|G0000000|G0000000|C0439234|G0000000
"The planned study population was 870 patients (580 to receive abagovomab, 290 to receive placebo).","The planned study population 870 patients (580 receive abagovomab, 290 receive placebo).",G0000000|C1301732|C0557651|C0032659|C1442061|C0030705|C1442061|C1514756|C1832044|C1442061|C1514756|C0032042
"Inclusion criteria included self-report of being African American, having smoked a minimum of 10 cigarettes a day continuously for at least the past year, at least one previous attempt to quit, a home address, a telephone number at which the patient could be reached, and weight more than 100 pounds.","Inclusion criteria included self-report African American, smoked minimum 10 cigarettes day continuously year, previous attempt quit, address, telephone patient reached, weight 100 pounds.",C0007637|C0243161|C0332257|C0681906|C0027567|C0596070|C0037366|C1524031|C0450371|C0677453|C0332173|G0000000|C0439234|C0205156|C1516084|C0748223|C0376649|C0039457|C0030705|C2584321|C0005910|C1442061|C0439219
"A total of 7,828 children were present at this survey.","A total 7,828 children survey.",G0000000|C0439175|C1442061|C0008059|C0038951
"Overall, our sample population was composed of 2,240 children from 146 villages in 112 townships in seven rural counties.","Overall, sample population composed 2,240 children 146 villages 112 townships rural counties.",C0282416|C0370003|C0032659|G0000000|C1442061|C0008059|C1442061|C0562518|C1442061|C1552925|C0240919|C0079170
"Eligible mothers were: English speaking, D.C. metropolitan area residents, self-identified as an ethnic minority, ≥18 years, <30 weeks pregnant and a smoker with a desire to quit.","Eligible mothers were: English speaking, D.C. metropolitan residents, self-identified ethnic minority, ≥18 years, <30 weeks pregnant smoker desire quit.",C1548635|C0026591|G0000000|C0376245|C0234856|C0012358|C0599587|C1320928|C0036588|C0015031|C0026192|G0000000|C0439234|C0450371|C0439230|C0549206|C0337664|C0871633|C0748223
"Inclusion and Exclusion Criteria, ALIAS Part 1 Trial Acute ischemic stroke Age 18 years or older Baseline NIH Stroke Scale (NIHSS) score of 6 or greater as assessed immediately prior to tPA treatment in the thrombolytic cohort, or immediately prior to randomization in the non-thrombolytic cohort Initiation of ALB/placebo treatment within 5 hours of stroke onset, and within 60 minutes of the start of IV tPA, if given Signed and dated informed consent","Inclusion Exclusion Criteria, ALIAS Part 1 Trial Acute ischemic stroke Age 18 Baseline NIH Stroke Scale (NIHSS) score 6 assessed prior tPA treatment thrombolytic cohort, prior randomization non-thrombolytic cohort Initiation ALB/placebo treatment 5 hours stroke onset, 60 minutes start IV tPA, Signed dated informed consent",C0007637|C0680251|C0243161|C0740885|C0449719|G0000000|C0008976|C0205178|C0475224|C0038454|C0001779|C0450371|C0168634|C0027468|C0038454|C0175659|C3476804|C0449820|G0000000|C1516048|C0332152|C0032143|C0039798|C0016018|C0599755|C0332152|C0034656|C1518422|C0599755|C0589507|C0032042|C0039798|G0000000|C0439227|C0038454|C0206132|C0450371|C0439232|C0439659|C0022326|C0032143|C1519316|G0000000|C1522154|C1511481
Participants for this study were dental patients aged 18 years and older who were seen for a nonemergency visit to the clinic.,Participants study dental patients aged 18 nonemergency visit clinic.,C0679646|C0557651|C0011365|C0030705|C0001779|C0450371|G0000000|C0545082|C0002424
"Among 638 infants (mean, 26 weeks’ gestational age; 50% male), 632 (99%) received the trial drug or placebo and 589 (92%) had a study outcome.","Among 638 infants (mean, 26 weeks’ gestational age; 50% male), 632 (99%) received trial drug placebo 589 (92%) study outcome.",G0000000|C1442061|C0021270|C0444504|C0450371|G0000000|C0439671|C0001779|C0450371|C0086582|C1442061|C0450371|C1514756|C0008976|C0013227|C0032042|C1442061|C0450371|C0557651|C1274040
We enrolled 2549 smokers.,We enrolled 2549 smokers.,G0000000|G0000000|G0000000|C0337664
It was conducted at Ain Shams University Maternity Hospital Neonatal Intensive Care Unit (NICU) from November 2012 till April 2014.,It conducted Ain Shams University Maternity Hospital Neonatal Intensive Care Unit (NICU) November 2012 till April 2014.,G0000000|C0004927|C0347129|C0073980|C0041740|C0681108|C0019994|C1552240|C0162425|C1947933|C0439148|C0021709|C3828767|G0000000|G0000000|C3715024|G0000000
"Patients with International Federation of Gynecology and Obstetrics stage III to IV ovarian cancer in complete clinical remission after primary surgery and platinum- and taxane-based chemotherapy were randomly assigned at a ratio of 2:1 in a phase III, double-blind, placebo-controlled, multicenter study.","Patients International Federation Gynecology Obstetrics stage III IV ovarian cancer complete clinical remission primary surgery platinum- taxane-based chemotherapy randomly assigned ratio 2:1 phase III, double-blind, placebo-controlled, multicenter study.",C0030705|C1512888|G0000000|C0018417|C0028773|C0205390|C0439070|C0022326|C0205065|C0006826|C0205197|C0205210|C0544452|C0205225|C0038894|C0032207|C0215136|C0013216|G0000000|C1516050|C0456603|G0000000|C0205390|C0439070|C0013072|C1706408|C0439743|C0557651
"160 921 women were recruited between Oct 14, 1990, and Sept 24, 1997.","160 921 women recruited Oct 14, 1990, Sept 24, 1997.",G0000000|C0043210|G0000000|C3828732|C0450371|G0000000|G0000000|C0450371|G0000000
"We conducted, in 121 breast cancer survivors receiving an AI and reporting arthralgia, a yearlong randomized trial of the impact of exercise versus usual care on arthralgia severity.","We conducted, 121 breast cancer survivors receiving AI reporting arthralgia, yearlong randomized trial impact exercise versus usual care arthralgia severity.",G0000000|C0004927|C1442061|C0006141|C0006826|C0206194|C1514756|C0003353|C0700287|C0003862|G0000000|C0034656|C0008976|C1825598|C0015259|G0000000|C3538928|C1947933|C0003862|C0439793
"Patients eligible for the present study had to have a confirmed diagnosis of CF substantiated either by the identification of two mutations known to cause CF (5) or by the sweat iontophoresis test (positive for CF if sweat Cl− concentrations greater than 60 mmol/L in at least two samples of 100 mg sweat [6]), be clinically stable at the time of enrolment and have at least two positive cultures for P aeruginosa within the past six months.","Patients eligible study confirmed diagnosis CF substantiated identification mutations CF (5) sweat iontophoresis test (positive CF sweat Cl− concentrations 60 mmol/L samples 100 sweat [6]), clinically stable time enrolment positive cultures P aeruginosa months.",C0030705|C1548635|C0557651|C0521093|C0011900|C0009738|G0000000|C0020792|C0026882|C0009738|G0000000|C0038984|C0022024|C0022885|C0439178|C0009738|C0038984|G0000000|C0086045|C0450371|C1532563|C0370003|C1442061|C0038984|G0000000|G0000000|C0205360|C0040223|C1516879|C0439178|C0010453|C0369773|G0000000|C0439231
"Patients with WAGR syndrome (n=69), DDS (n=37) or male GU anomalies (n=217) were excluded from the non-WT1-syndromic cohort.","Patients WAGR syndrome (n=69), DDS (n=37) male GU anomalies (n=217) excluded non-WT1-syndromic cohort.",C0030705|G0000000|C0039082|C0369718|G0000000|C0369718|C0086582|C3887515|C0000769|C0369718|C1554077|C1518422|C0599755
Women were eligible if their arthralgia started after initiation of an AI or if they had preexisting joint pain that was exacerbated by AI use.,Women eligible arthralgia started initiation AI preexisting joint pain exacerbated AI use.,C0043210|C1548635|C0003862|C1272689|C0589507|C0003353|C2347662|C0022417|C0030193|C0436331|C0003353|C0042153
"Eligible subjects were at least 18 years old, smoked ≥ 15 cigarettes per day (cpd), had smoked regularly for ≥ 3 years, had an expired air carbon monoxide (CO) level of ≥ 10 parts per million (ppm), wanted to reduce their smoking, and had previously made at least one failed quit attempt (i.e., all participants had experienced difficulties trying to stop on their own), but did not have to be motivated to quit smoking.","Eligible subjects 18 old, smoked ≥ 15 cigarettes day (cpd), smoked regularly ≥ 3 years, expired air carbon monoxide (CO) level ≥ 10 (ppm), reduce smoking, failed quit attempt (i.e., participants experienced difficulties own), motivated quit smoking.",C1548635|C0681850|C0450371|C0580836|C0037366|G0000000|C0450371|C0677453|C0332173|C0085988|C0037366|G0000000|G0000000|G0000000|C0439234|C0011065|C0001861|C0007009|G0000000|C3245499|C0441889|G0000000|C0450371|C0439187|G0000000|C0037369|C0231175|C0748223|C1516084|C0683454|C0679646|C0237607|C1299586|G0000000|G0000000|C0748223|C0037369
"This cluster-RCT included a total of 2,240 sample children and spanned 112 townships in seven of the poorest rural counties in Qiandongnan Prefecture in Guizhou Province (Figure 1 ).","This cluster-RCT included total 2,240 sample children spanned 112 townships poorest rural counties Qiandongnan Prefecture Guizhou Province (Figure 1 ).",G0000000|C1555715|C0332257|C0439175|C1442061|C0370003|C0008059|C1711300|C1442061|C1552925|C0032854|C0240919|C0079170|G0000000|C1709636|G0000000|C1514578|G0000000|G0000000|G0000000
"We did not include in the study patients who were younger than 15 or older than 76 years; patients with a GCS score of 3 upon admission and neurological signs of brain death (bilateral arreactive midryasis and loss of brainstem reflexes); and patients who were pregnant, had barbiturate allergy or intolerance, or had a history of severe cardiac ventricular dysfunction with an ejection fraction under 35%.","We study patients 15 76 years; patients GCS score 3 admission neurological signs brain death (bilateral arreactive midryasis loss brainstem reflexes); patients pregnant, barbiturate allergy intolerance, history severe cardiac ventricular dysfunction ejection fraction 35%.",G0000000|C0557651|C0030705|C0450371|C0450371|C0439234|C0030705|G0000000|C0449820|G0000000|C0184666|C0205494|C0220912|C0006104|C0011065|C0238767|G0000000|G0000000|C1517945|C0006121|C0034929|C0030705|C0549206|C0004745|C0002111|C0231199|C0019664|C0205082|C0018787|C0018827|C0031847|C0302131|C1264633|C0450371
"A total of 502 patients were randomly assigned on this study, as shown in the CONSORT diagram (Fig 1).","A total 502 patients randomly assigned study, CONSORT diagram (Fig 1).",G0000000|C0439175|C1442061|C0030705|G0000000|C1516050|C0557651|G0000000|C0681494|C0349966|G0000000
Patients were accrued at multiple institutions from December 2006 to February 2009.,Patients accrued multiple institutions December 2006 February 2009.,C0030705|G0000000|C0439064|C1272753|C3830550|G0000000|C3830166|G0000000
"Of the 83 patients who were enrolled, 62 patients completed the study.","Of 83 patients enrolled, 62 patients completed study.",G0000000|C0450371|C0030705|G0000000|C0450371|C0030705|C0205197|C0557651
"Of the 410 patients randomized, mean age was 48 years, 65% were female, 41% had less than a high school education, 51% had an annual household income of less than $8,000, and the average number of cigarettes smoked per day was 20.","Of 410 patients randomized, age 48 years, 65% female, 41% school education, 51% annual household income $8,000, average cigarettes smoked day 20.",G0000000|C1442061|C0030705|C0034656|C0001779|C0450371|C0439234|C0450371|C0015780|C0450371|C0036375|C0013621|C0450371|C0332181|C0020052|C0021162|C1442061|C1510992|C0677453|C0037366|C0332173|C0450371
A randomized double-masked Phase 2 clinical trial was conducted in 14 centers of the Eunice Kennedy Shriver NICHD Neonatal Research Network(NRN).,A randomized double-masked Phase 2 clinical trial conducted 14 centers Eunice Kennedy Shriver NICHD Neonatal Research Network(NRN).,G0000000|C0034656|C0013072|C0205390|G0000000|C0205210|C0008976|C0004927|C0450371|C0205099|C1029979|G0000000|G0000000|C1513896|C1552240|C0035168|C0150775
"From January to October 2010, 125 infants ≤29weeks gestation were randomized and 122 received treatment during the time for the designed 96 infants to complete the protocol (Figure 1).","From January October 2010, 125 infants ≤29weeks gestation randomized 122 received treatment time designed 96 infants complete protocol (Figure 1).",G0000000|C3829466|C3828732|G0000000|C1442061|C0021270|G0000000|C0032961|C0034656|C1442061|C1514756|C0039798|C0040223|C1707689|C0450371|C0021270|C0205197|C0442711|G0000000|G0000000
Adults with suspected acute stroke presenting to NEAS North of Tyne research trained paramedics who fulfil the following criteria are eligible: • Adults ≥ 40 years old • New unilateral arm weakness thought to be due to acute stroke within 3 hours of symptom onset • Hypertension as defined by systolic BP >160 mm Hg on two consecutive seated or lying readings taken 5 - 10 minutes apart • Conscious (eyes open spontaneously i.e.,Adults suspected acute stroke NEAS North Tyne trained paramedics fulfil criteria eligible: • Adults ≥ 40 • New unilateral arm weakness acute stroke 3 hours symptom onset • Hypertension defined systolic BP >160 mm Hg consecutive seated lying readings 5 - 10 minutes • Conscious (eyes spontaneously i.e.,C0001675|C0332147|C0205178|C0038454|C1420386|C1709269|G0000000|C0336809|C0030450|C1550543|C0243161|C1548635|G0000000|C0001675|G0000000|C0450371|G0000000|C0205314|C0205092|C0446516|C3714552|C0205178|C0038454|G0000000|C0439227|C1457887|C0206132|G0000000|C0020538|C1704788|C0039155|C0037623|C1442061|G0000000|C0025424|C1707491|C0277814|C0038846|C0034754|G0000000|G0000000|C0450371|C0439232|G0000000|C0234421|C0015392|G0000000|C0683454
"The study was conducted in Rakhine State, Western Myanmar.","The study conducted Rakhine State, Western Myanmar.",G0000000|C0557651|C0004927|G0000000|C1301808|C1705493|C0006416
We enrolled 2637 tobacco users at their dental health visit.,We enrolled 2637 tobacco users dental health visit.,G0000000|G0000000|G0000000|C0040329|C1706077|C0011365|C0018684|C0545082
"We excluded 5 of 137 potentially eligible patients for geographical reasons, language problems, or difficulties with follow up.","We excluded 5 137 eligible patients geographical reasons, language problems, difficulties follow up.",G0000000|C1554077|G0000000|C1442061|C1548635|C0030705|C0017447|C0392360|C0023008|C1546466|C1299586|C0332283|G0000000
"Cross-sectional study with longitudinal follow-up at 48 academic, community hospital, and private practice sites in the US and Germany, conducted between December 2016 and November 2017, that included average-risk women aged 40–75 years with heterogeneously dense or extremely dense breasts undergoing routine screening.","Cross-sectional study longitudinal follow-up 48 academic, community hospital, private practice sites US Germany, conducted December 2016 November 2017, included average-risk women aged 40–75 heterogeneously dense extremely dense breasts undergoing routine screening.",C0552389|C0557651|C0205127|C0589120|C0450371|C1510747|C0009462|C0019994|C0033175|C0237607|C0205145|G0000000|C0017480|C0004927|C3830550|G0000000|C3828767|G0000000|C0332257|C1510992|C0043210|C0001779|G0000000|G0000000|C0439794|C0205403|C0439794|C0006141|G0000000|C0205547|C0220908
"At the next occurrence of ear pain the children were examined, and those with a red or pale, bulging, thickened tympanic membrane were included in the study.","At occurrence ear pain children examined, red pale, bulging, thickened tympanic membrane included study.",G0000000|C0243132|C0013443|C0030193|C0008059|C0332128|C0332575|C0030232|C0038999|C0205400|C0041445|C0025255|C0332257|C0557651
"A total of 3935 children, aged 1 to 5 years at entry, 1967 from 25 anganwadi centers allocated “usual care” and 1968 from 25 anganwadi centers allocated “usual care plus albendazole” were enrolled in the study from April to August, 1994 and followed up until December, 1996 (Figure 1).","A total 3935 children, aged 1 5 entry, 1967 25 anganwadi centers allocated “usual care” 1968 25 anganwadi centers allocated “usual care albendazole” enrolled study April August, 1994 December, 1996 (Figure 1).",G0000000|C0439175|G0000000|C0008059|C0001779|G0000000|G0000000|C1705654|G0000000|C0450371|G0000000|C0205099|G0000000|G0000000|G0000000|G0000000|C0450371|G0000000|C0205099|G0000000|G0000000|C1947933|G0000000|G0000000|C0557651|C3715024|C3831448|G0000000|C3830550|G0000000|G0000000|G0000000
"Breast cancer survivors were recruited between June 1, 2010, and December 30, 2012, from five hospitals in Connecticut through the Rapid Case Ascertainment Shared Resource of the Yale Cancer Center, a field arm of the Connecticut Tumor Registry.","Breast cancer survivors recruited June 1, 2010, December 30, 2012, hospitals Connecticut Rapid Case Ascertainment Shared Resource Yale Cancer Center, field arm Connecticut Tumor Registry.",C0006141|C0006826|C0206194|G0000000|C3829443|G0000000|G0000000|C3830550|C0450371|G0000000|C0019994|C0009778|C0456962|C0868928|G0000000|C0237876|C0035201|G0000000|C0006826|C0205099|C0440042|C0446516|C0009778|C0027651|C0034975
The inclusion criteria were 1) dysphagia after subacute ischemic stroke and 2) disease localized to a unilateral cerebral hemisphere (as documented by computed tomography or MRI).,The inclusion criteria 1) dysphagia subacute ischemic stroke 2) disease localized unilateral cerebral hemisphere (as documented computed tomography MRI).,G0000000|C0007637|C0243161|G0000000|C0011168|C0205365|C0475224|C0038454|G0000000|C0012634|C0392752|C0205092|G0000000|C0205139|G0000000|C1301725|C1441526|C0040395|C0024485
Eligibility criteria included: a) smoking at least one cigarette per day for the preceding 7 days; b) < 26 weeks gestation; c) > 16 ears of age; d) able to speak English or Spanish; e) intent to carry pregnancy to term; f) stable residence.,Eligibility criteria included: a) smoking cigarette day preceding 7 days; b) < 26 weeks gestation; c) > 16 ears age; d) speak English Spanish; e) intent carry pregnancy term; f) stable residence.,C0013893|C0243161|C0332257|G0000000|C0037369|C0677453|C0332173|C0332152|G0000000|C0439228|G0000000|G0000000|C0450371|C0439230|C0032961|G0000000|G0000000|C0450371|C0013443|C0001779|C0073187|C0234856|C0376245|C0086409|G0000000|C0162425|C0206243|C0032961|C0233324|C0016327|C0205360|C0237096
"Their mean age was 46 (range 20-68) years, mean baseline cigarette consumption was 25 cpd (range 13*-70), and mean age at onset of smoking was 18 years (range 8-42).","Their age 46 (range 20-68) years, baseline cigarette consumption 25 cpd (range 13*-70), age onset smoking 18 (range 8-42).",G0000000|C0001779|C0450371|C1514721|C0450371|C0439234|C0168634|C0677453|C0009830|C0450371|C0085988|C1514721|C0450371|C0001779|C0206132|C0037369|C0450371|C1514721|C0450371
Setting Eastern Uganda.,Setting Eastern Uganda.,C0542559|C1707877|C0041573
Hospitalized patients are recruited from two health-care systems in San Diego County.,Hospitalized patients recruited health-care systems San Diego County.,C0701159|C0030705|G0000000|C0086388|C0449913|C1826357|G0000000|C0079170
"Pregnant smokers are not included in this study because there is still debate about the advisability of using nicotine patches during pregnancy [19,20].","Pregnant smokers included study debate advisability nicotine patches pregnancy [19,20].",C0549206|C0337664|C0332257|C0557651|C0870392|G0000000|C0028040|C0994894|C0032961|C0450371
Patients with dysphagia that occurred after an acute brain injury and whose symptom onset occurred after <3 months were enrolled.,Patients dysphagia occurred acute brain injury symptom onset occurred <3 months enrolled.,C0030705|C0011168|C1709305|C0205178|C0006104|C3263722|C1457887|C0206132|C1709305|G0000000|C0439231|G0000000
"A total of 2,179 students were enrolled in our study at baseline in April 2013: 1,084 children in the intervention group and 1,095 children in the control group.","A total 2,179 students enrolled study baseline April 2013: 1,084 children intervention 1,095 children control group.",G0000000|C0439175|C1442061|C0038492|G0000000|C0557651|C0168634|C3715024|G0000000|C1442061|C0008059|C0886296|C1442061|C0008059|C0243148|C0441833
"This prospective, multicenter, randomized trial enrolled 502 patients with hemoglobin (Hb) less than 11 g/dL who were undergoing chemotherapy for nonmyeloid malignancies.","This prospective, multicenter, randomized trial enrolled 502 patients hemoglobin (Hb) 11 g/dL undergoing chemotherapy nonmyeloid malignancies.",G0000000|C0023981|C0439743|C0034656|C0008976|G0000000|C1442061|C0030705|C0019046|C0019046|C0450371|C0439267|G0000000|C0013216|G0000000|C0006826
Patients were also excluded if another member of the same household was enrolled in the trial.,Patients excluded household enrolled trial.,C0030705|C1554077|C0020052|G0000000|C0008976
"In this randomized clinical trial including 110 frail patients undergoing colorectal surgery (87 [79.1%] minimally invasive) within an enhanced recovery pathway, prehabilitation did not affect postoperative complications (measured using the Comprehensive Complication Index) compared with postoperative rehabilitation.","In randomized clinical trial including 110 frail patients undergoing colorectal surgery (87 [79.1%] minimally invasive) enhanced recovery pathway, prehabilitation affect postoperative complications (measured Comprehensive Complication Index) compared postoperative rehabilitation.",G0000000|C0034656|C0205210|C0008976|C0332257|C1442061|C0871754|C0030705|G0000000|C0555952|C0038894|C0450371|C0450371|G0000000|C0205281|C2349975|C0237820|C1704259|G0000000|C0001721|C0032790|C0009566|C0444706|C1880156|C0009566|C0918012|C1707455|C0032790|C0034991
This study included 18 stroke patients with dysphagia and was performed at I Hospital in Korea from 2014–2015.,This study included 18 stroke patients dysphagia performed I Hospital Korea 2014–2015.,G0000000|C0557651|C0332257|C0450371|C0038454|C0030705|C0011168|C0884358|C0021966|C0019994|C0022771|G0000000
"In this randomized clinical trial that included 638 premature infants younger than 28 weeks’ gestational age, treatment with myo-inositol for up to 10 weeks did not reduce the risk of type 1 retinopathy of prematurity or death compared with placebo (29% vs 21%, respectively).","In randomized clinical trial included 638 premature infants 28 weeks’ gestational age, treatment myo-inositol 10 weeks reduce risk type 1 retinopathy prematurity death compared placebo (29% 21%, respectively).",G0000000|C0034656|C0205210|C0008976|C0332257|C1442061|C0151526|C0021270|C0450371|G0000000|C0439671|C0001779|C0039798|C0021547|C0450371|C0439230|G0000000|C0035647|C0332307|G0000000|C0035309|C0021294|C0011065|C1707455|C0032042|C0450371|C0450371|G0000000
"Participants were on average 27.5 ± 5.4 years old, 81 % were single, 69 % unemployed and 96 % were Medicaid eligible.","Participants average 27.5 ± 5.4 old, 81 % single, 69 % unemployed 96 % Medicaid eligible.",C0679646|C1510992|C0450371|G0000000|G0000000|C0580836|C0450371|G0000000|C0037179|C0450371|G0000000|C0041674|C0450371|G0000000|C0025071|C1548635
"Of the 83 patients, 62 completed the study, sertaconazole (n = 20), terbinafine (n = 22) and luliconazole (n = 20).","Of 83 patients, 62 completed study, sertaconazole (n = 20), terbinafine (n = 22) luliconazole (n = 20).",G0000000|C0450371|C0030705|C0450371|C0205197|C0557651|C0074391|C0369718|G0000000|C0450371|C0076110|C0369718|G0000000|C0450371|C1956280|C0369718|G0000000|C0450371
"Subjects will be 1,640 English- and Spanish-speaking adult smokers (18 years and over) hospitalized at one of the participating hospitals.","Subjects 1,640 English- Spanish-speaking adult smokers (18 years over) hospitalized participating hospitals.",C0681850|C1442061|C0376245|C0086409|C0001675|C0337664|G0000000|C0205136|C0701159|C0679823|C0019994
"Women under treatment for psychiatric illness, alcoholism or drug addiction were excluded.","Women treatment psychiatric illness, alcoholism drug addiction excluded.",C0043210|C0039798|C0205487|C0221423|C0001973|C0013227|C0085281|C1554077
"Eligibility criteria included internal or family medicine specialty, plans to continue practicing in current location for at least 1 year, at least 75 patient visits per week, primarily English-speaking patients, and fewer than 25% geriatric patients.","Eligibility criteria included internal family medicine specialty, plans continue practicing current location 1 year, 75 patient visits week, English-speaking patients, fewer 25% geriatric patients.",C0013893|C0243161|C0332257|C0205102|C0015576|C0013227|C0037778|C0270724|C0549178|C0237607|C0521116|C0450429|G0000000|C0439234|C0450371|C0030705|C0545082|C0332174|C0376245|C0030705|C0205388|C0450371|C1704440|C0030705
"Twenty-four patients who had dysphagia after ischemic stroke were recruited, and they were divided into two groups after matching for age and stroke lesion.","Twenty-four patients dysphagia ischemic stroke recruited, divided matching age stroke lesion.",C3715070|C0030705|C0011168|C0475224|C0038454|G0000000|C0332849|C0150103|C0001779|C0038454|C0221198
"Eligible participants were physically inactive (< 90 minutes per week of physical activity in past 6 months and no strength training in past year), postmenopausal women diagnosed 0.5 to 4.0 years before enrollment with hormone receptor–positive stage I to III breast cancer who had been receiving an AI for at least 6 months.","Eligible participants physically inactive (< 90 minutes week physical activity 6 months strength training year), postmenopausal women diagnosed 0.5 4.0 enrollment hormone receptor–positive stage I III breast cancer receiving AI 6 months.",C1548635|C0679646|G0000000|C0205254|G0000000|C0450371|C0439232|C0332174|C0031809|C0205177|G0000000|C0439231|C0237897|C0040607|C0439234|C0232970|C0043210|C0011900|G0000000|G0000000|C1516879|C0019932|G0000000|C0205390|C0021966|C0439070|C0006141|C0006826|C1514756|C0003353|G0000000|C0439231
The planned sample size was at least 36 infants in each GA stratum who received study drug and completed 4 blood samples.,The planned sample size 36 infants GA stratum received study drug completed 4 blood samples.,G0000000|C1301732|C0370003|C0456389|C0450371|C0021270|C0016993|G0000000|C1514756|C0557651|C0013227|C0205197|G0000000|C0005767|C0370003
"Thirty patients were enrolled, and mean patient age was 68.2 years.","Thirty patients enrolled, patient age 68.2 years.",C3816446|C0030705|G0000000|C0030705|C0001779|C0450371|C0439234
"A total of 32 patients (17 women) with CF, mean (± SD) age 18.5±8.6 years, completed the study.","A total 32 patients (17 women) CF, (± SD) age 18.5±8.6 years, completed study.",G0000000|C0439175|C0450371|C0030705|C0450371|C0043210|C0009738|G0000000|C2699239|C0001779|G0000000|C0439234|C0205197|C0557651
"In order to detect a 50% reduction in the incidence of falciparum malaria, with 80% power at a 5% significance level, a total of 10 village pairs were required with an average of 420 children per village, amounting to a total sample size of 8,400 children.","In detect 50% reduction incidence falciparum malaria, 80% power 5% significance level, total 10 village pairs required average 420 children village, amounting total sample size 8,400 children.",G0000000|C0442726|C0450371|C0301630|C0021149|G0000000|C0024530|C0450371|C0032863|G0000000|C0237881|C0441889|C0439175|C0450371|C0562518|C1709450|C1514873|C1510992|C1442061|C0008059|C0562518|C1265611|C0439175|C0370003|C0456389|C1442061|C0008059
"Of 110 patients randomized, mean (SD) age was 78 (7) years; 52 (47.3%) were men and 58 (52.7%) were women; 31 (28.2%) had rectal cancer; and 87 (79.1%) underwent minimally invasive surgery.","Of 110 patients randomized, (SD) age 78 (7) years; 52 (47.3%) 58 (52.7%) women; 31 (28.2%) rectal cancer; 87 (79.1%) underwent minimally invasive surgery.",G0000000|C1442061|C0030705|C0034656|G0000000|C0001779|C0450371|G0000000|C0439234|C0450371|C0450371|C0450371|C0450371|C0043210|C0450371|C0450371|C0205052|C0006826|C0450371|C0450371|G0000000|G0000000|C0205281|C0038894
52 women were recruited during pregnancy with a mean gestational age 18.5 ± 5.0 weeks and followed through delivery.,52 women recruited pregnancy gestational age 18.5 ± 5.0 weeks delivery.,C0450371|C0043210|G0000000|C0032961|C0439671|C0001779|C0450371|G0000000|G0000000|C0439230|C0011209
"There were 2345 live-born children of whom 2016 were later randomised into the childhood intervention trial, with 1622 remaining in follow-up at age 5 years (69%).","There 2345 live-born children 2016 randomised childhood intervention trial, 1622 remaining follow-up age 5 (69%).",G0000000|G0000000|C1548795|C0008059|G0000000|G0000000|C0231335|C0886296|C0008976|G0000000|C1527428|C0589120|C0001779|G0000000|C0450371
"A total of 418 patients were assessed for eligibility from September 7, 2015, through June 19, 2019.","A total 418 patients assessed eligibility September 7, 2015, June 19, 2019.",G0000000|C0439175|C1442061|C0030705|C1516048|C0013893|C3828193|G0000000|G0000000|C3829443|C0450371|G0000000
"Patients admitted to our intensive care unit (ICU) between May 2002 and July 2007 with a severe TBI (Glasgow Coma Scale [GCS] score after nonsurgical resuscitation ≤ 8) and presenting with refractory ICH (ICP > 20 mmHg), and who underwent first-level measures in accordance with the BTF Guidelines [7], were included.","Patients admitted intensive care unit (ICU) May 2002 July 2007 severe TBI (Glasgow Coma Scale [GCS] score nonsurgical resuscitation ≤ 8) refractory ICH (ICP > 20 mmHg), underwent first-level measures BTF Guidelines [7], included.",C0030705|C0184666|C0162425|C1947933|C0439148|C0021708|G0000000|G0000000|C3829447|G0000000|C0205082|C0876926|G0000000|C0009421|C0175659|G0000000|C0449820|C1518388|C0035273|G0000000|G0000000|C0205269|C0019191|C1881201|G0000000|C0450371|C0439475|G0000000|C0563053|C0079809|C1424602|C0162791|G0000000|C0332257
The mean ages were 63.5±11.4 years in the NMES/TDT group and 66.7±9.5 years in the TDT group.,The ages 63.5±11.4 NMES/TDT 66.7±9.5 TDT group.,G0000000|C0001779|G0000000|C2985393|G0000000|C3887634|C0441833
"In total 8,175 children under 10 years of age were followed up for 10 months, which included the main malaria transmission period.","In total 8,175 children 10 age 10 months, included main malaria transmission period.",G0000000|C0439175|C1442061|C0008059|C0450371|C0001779|C0450371|C0439231|C0332257|C0205225|C0024530|C0040722|C0439531
Infants who developed complications were excluded from the study.,Infants developed complications excluded study.,C0021270|G0000000|C0009566|C1554077|C0557651
"A total of 2,028 participants (93% of the enrolled sample) were included in the follow-up analysis: 1,000 children in the intervention group and 1,028 children in the control group.","A total 2,028 participants (93% enrolled sample) included follow-up analysis: 1,000 children intervention 1,028 children control group.",G0000000|C0439175|C1442061|C0679646|C0450371|G0000000|C0370003|C0332257|C0589120|C0002778|C1442061|C0008059|C0886296|C1442061|C0008059|C0243148|C0441833
The mean age of participants was 25 years and 64% had one or more children.,The age participants 25 64% children.,G0000000|C0001779|C0679646|C0450371|C0450371|C0008059
"Additional exclusion factors, in order, included WT in an extra-renal site (n=22), a missing histology record (n=276) or a histologic type recorded as rhabdoid tumor of the kidney, clear cell sarcoma of the kidney or as another rare, indeterminant or non-WT type (n=665).","Additional exclusion factors, order, included WT extra-renal site (n=22), missing histology record (n=276) histologic type recorded rhabdoid tumor kidney, cell sarcoma kidney rare, indeterminant non-WT type (n=665).",C1524062|C0680251|C1521761|C1705175|C0332257|C2700323|C0022646|C0205145|C0369718|C1551393|C0019638|C0034869|C0369718|C0205462|C0332307|C0034869|G0000000|C0027651|C0022646|C0007634|C1261473|C0022646|C0521114|G0000000|C1518422|C0332307|C0369718
"Women were excluded if they had a screening breast ultrasound within the past 12 months, or ever had a breast-MRI, a molecular breast imaging study, or a contrast-enhanced mammogram, or would qualify for full-protocol breast-MRI based on American Cancer Society guidelines.","Women excluded screening breast ultrasound 12 months, breast-MRI, molecular breast imaging study, contrast-enhanced mammogram, qualify full-protocol breast-MRI based American Cancer Society guidelines.",C0043210|C1554077|C0220908|C0006141|C0041618|C0450371|C0439231|C0344104|C1521991|C0006141|C0011923|C0557651|C0009924|C0024671|G0000000|C1507394|C0344104|C1527178|C0596070|C0006826|C0037455|C0162791
"Between March 2011 and June 2012, patients were enrolled in this study with a diagnosis of dysphagia by VFSS within 10 days after stroke.","Between March 2011 June 2012, patients enrolled study diagnosis dysphagia VFSS 10 days stroke.",G0000000|C3829202|G0000000|C3829443|G0000000|C0030705|G0000000|C0557651|C0011900|C0011168|G0000000|C0450371|C0439228|C0038454
